FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

329714006: Product containing precisely indometacin 25 milligram/1 each conventional release oral capsule (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
3679837011 Indomethacin 25 mg oral capsule en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) IPS terminology module (core metadata concept)
3679838018 Indometacin 25 mg oral capsule en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) IPS terminology module (core metadata concept)
3679839014 Product containing precisely indometacin 25 milligram/1 each conventional release oral capsule (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) IPS terminology module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Indometacin 25 mg oral capsule Is a Indometacin only product true Inferred relationship Some
Indometacin 25 mg oral capsule Has manufactured dose form Oral capsule true Inferred relationship Some
Indometacin 25 mg oral capsule Has unit of presentation Capsule (unit of presentation) true Inferred relationship Some
Indometacin 25 mg oral capsule Has basis of strength substance (attribute) Indometacin true Inferred relationship Some 1
Indometacin 25 mg oral capsule Has presentation strength numerator unit mg true Inferred relationship Some 1
Indometacin 25 mg oral capsule Has presentation strength denominator unit (attribute) Capsule (unit of presentation) true Inferred relationship Some 1
Indometacin 25 mg oral capsule Has precise active ingredient Indometacin true Inferred relationship Some 1

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

International Patient Summary

Back to Start